Formosa Pharmaceuticals Announces Licensing Agreement with Rxilient, for Commercialization of Clobetasol Propionate Ophthalmic Suspension for the Treatment of Inflammation and ...

Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TW) announced today that the company has entered into an exclusive licensing agreement with Rxilient Medical Pte. Ltd. ("Rxilient"), for exclusive ...
Nasdaq

Taiwan's Formosa shuts hydrocracker following fire - spokesman

Taiwan's Formosa Petrochemical Corp has shut its 36,000 barrel-per-day hydrocracker at its Mailiao refinery following a fire last week, the company spokesman said on Tuesday. By Florence Tan and ...
Nasdaq

Taiwan's Formosa plans to increase refinery output in May

Taiwan's Formosa Petrochemical Corp plans to ramp up operating rates at its refinery in May to 74% once it restarts a gasoline-making unit after maintenance and as refining margins have improved, the ...
Digi Times

Formosa Smart Energy unveils Taiwan's largest battery cell plant, eyes Southeast Asian expansion

Formosa Smart underscores its ambitions to position Taiwan as a regional battery hub. Chairman Sandy Wang called the facility Taiwan's largest battery cell factory, with plans to scale capacity beyond ...